UCB (OTCMKTS:UCBJY) Stock Passes Above Fifty Day Moving Average of $60.91

UCB SA (OTCMKTS:UCBJY)’s stock price crossed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $60.91 and traded as high as $65.57. UCB shares last traded at $65.57, with a volume of 18,593 shares trading hands.

UCB Price Performance

The company has a 50-day moving average of $61.44 and a 200-day moving average of $49.03.

UCB Cuts Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 29th will be given a dividend of $0.4574 per share. This represents a dividend yield of 0.71%. The ex-dividend date of this dividend is Friday, April 26th. UCB’s dividend payout ratio is 46.55%.

About UCB

UCB SA, a biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide. The company's primary products include Cimzia for inflammatory TNF mediated diseases, as well as ankylosing spondylitis, axial spondyloarthritis, Crohn's disease, non-radiographic axial spondyloarthritis, plaque psoriasis, psoriatic arthritis, and rheumatoid arthritis; Vimpat, Keppra, and Briviact for epilepsy; Neupro for Parkinson's disease and restless legs syndrome; Nayzilam, a nasal spray rescue treatment for epilepsy seizure clusters; and Zyrtec and Xyzal for allergies.